We are pleased to announce that we are initiating coverage on MetAlert Inc. (OTCPK: MLRT), a company at the forefront of tracking technology for health monitoring and gun safety. MLRT's proprietary real-time tracking solutions offer significant advancements in remote monitoring, tracking, and data collection.
Among MLRT's notable offerings are the GPS SmartSoles, which integrate GPS technology into shoe insoles. This innovation is particularly vital for monitoring elderly individuals and those with cognitive disorders such as Alzheimer's, dementia, and autism. Additionally, MLRT's GunAlert device is designed to enhance gun safety by notifying owners of any unauthorized movement or use, with a strategic focus on gaining endorsements from law enforcement and government agencies.
MLRT's revenue model encompasses upfront hardware sales, as well as recurring revenue from subscriptions and licensing fees. With an estimated 11 million ADA patients in the US alone and a projected growth trajectory in the global patient monitoring devices market, MLRT is positioned to tap into significant market opportunities.
Moving forward, the effectiveness of MLRT's upcoming marketing campaigns will be critical in gauging market acceptance of its products.
*FRC provides issuer paid coverage.
*Past performance is not indicative of future results